JAWAD RIAZ: Open Payments
NPI 1962425280 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 23 payments from 12 companies in 2025. Trend: 2023 $509 · 2024 $311 · 2025 $671
Food & beverage: $471Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Lundbeck LLC | 3 | $73 |
| ABBVIE INC. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
Products named: SPRAVATO, REXULTI, VRAYLAR, INVEGA SUSTENNA, INGREZZA, AUSTEDO XR, Auvelity, CAPLYTA.
Industry payments across TX — which companies pay providers there.
